Niclosamide - encapsulated lipid nanoparticles for the reversal of pulmonary fibrosis.

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

"This work was supported by the Foundation of 10.13039/501100004829Science and Technology Department of Sichuan Province (NO.2022NSFSC1465, 2023NSFSC0525), Post-Doctor Research Project, 10.13039/501100013365West China Hospital, Sichuan University (NO.2021HXBH086), the 10.13039/501100004912Sichuan University postdoctoral interdisciplinary Innovation Fund (NO.10822041A2118) and Full-Time Postdoctoral Research Fund of 10.13039/501100004912Sichuan University (NO. 20826041F4134). We also thank Sichuan Greentech Bioscience Co., Ltd. for their assistance in the Pharmacokinetic profile, tissue distribution of Ncl-Lips. Yan Yu: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. Hongyao Liu: Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft. Liping Yuan: Investigation, Methodology. Meng Pan: Investigation, Methodology. Zhongwu Bei: Methodology. Tinghong Ye: Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Writing – review & editing. Zhiyong Qian: Conceptualization, Funding acquisition, Supervision, Writing – review & editing."